{"component": "definition", "props": {"groups": [{"snippet": "Notice. Each party to this Agreement will promptly notify each other party to this Agreement in writing if it or, to its knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any Bad Actor Disqualification.", "snippet_links": [{"key": "party-to-this-agreement", "type": "clause", "offset": [13, 36]}, {"key": "promptly-notify", "type": "clause", "offset": [42, 57]}, {"key": "other-party", "type": "clause", "offset": [63, 74]}, {"key": "agreement-in-writing", "type": "clause", "offset": [83, 103]}, {"key": "any-person", "type": "clause", "offset": [132, 142]}, {"key": "the-securities-act", "type": "clause", "offset": [177, 195]}, {"key": "subject-to", "type": "clause", "offset": [204, 214]}, {"key": "bad-actor-disqualification", "type": "definition", "offset": [219, 245]}], "samples": [{"hash": "3fGcII74fnA", "uri": "/contracts/3fGcII74fnA#bad-actor", "label": "Stockholders Agreement (Harley-Davidson, Inc.)", "score": 36.1533203125, "published": true}, {"hash": "gcVOhVuczaF", "uri": "/contracts/gcVOhVuczaF#bad-actor", "label": "Investors\u2019 Rights Agreement (Aardvark Therapeutics, Inc.)", "score": 36.0609169006, "published": true}, {"hash": "2pwPaxoBFXv", "uri": "/contracts/2pwPaxoBFXv#bad-actor", "label": "Investors\u2019 Rights Agreement (Aardvark Therapeutics, Inc.)", "score": 35.8117713928, "published": true}], "size": 25, "hash": "c74360e683a0bb9c002aad27ffafd1f8", "id": 1}, {"snippet": "means a Person who:", "snippet_links": [{"key": "a-person", "type": "clause", "offset": [6, 14]}], "samples": [{"hash": "9z7Hb1XhHZq", "uri": "https://sbg.colorado.gov/sites/sbg/files/083122_1_CCR_212-3_Proposed_Redlines.pdf", "label": "Notice", "score": 15.3312797546, "published": false}, {"hash": "dkHHXPWmpLo", "uri": "https://sbg.colorado.gov/sites/sbg/files/documents/230912%20Permanent%20Rule%20Revision%20Redlines.pdf", "label": "sbg.colorado.gov", "score": 11.845995903, "published": false}, {"hash": "eASEA16QF22", "uri": "https://sbg.colorado.gov/sites/sbg/files/101122%201%20CCR%20212-3%20FINAL%20ADOPTED%20RULES%20(1)_0.pdf", "label": "sbg.colorado.gov", "score": 11.3915128708, "published": false}], "size": 15, "hash": "685131bbe840d06c12676ab77c3f88a6", "id": 2}, {"snippet": "means a person who has committed a Bad Act.", "snippet_links": [{"key": "a-person", "type": "clause", "offset": [6, 14]}, {"key": "bad-act", "type": "definition", "offset": [35, 42]}], "samples": [{"hash": "kiwKpnnsBHJ", "uri": "/contracts/kiwKpnnsBHJ#bad-actor", "label": "Subscription Agreement", "score": 36.3283462524, "published": true}, {"hash": "7SlcX5SoWMc", "uri": "/contracts/7SlcX5SoWMc#bad-actor", "label": "Subscription Agreement", "score": 36.2134552002, "published": true}, {"hash": "61w3to943KZ", "uri": "/contracts/61w3to943KZ#bad-actor", "label": "Subscription Agreement", "score": 34.8779449463, "published": true}], "size": 12, "hash": "970b8a6afbe5f33284f44c34fcd3b532", "id": 3}, {"snippet": "means an issuer; any predecessor of an issuer; any affiliated issuer; any director, executive officer, other officer participating in an offering, general partner or managing member of the issuer; any beneficial owner of twenty percent (20%) or more of the issuer\u2019s outstanding voting equity securities, calculated on the basis of voting power; any promoter connected with the issuer in any capacity at the time of such sale (including any director, executive officer, other officer participating in the offering, general partner or managing member of the promoter); any investment manager of an issuer that is a pooled investment fund; any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with such sale of securities; any general partner or managing member of any such investment manager or solicitor; or any director, executive officer or other officer participating in the offering of any such investment manager or solicitor or general partner or managing member of such investment manager or solicitor; who:", "snippet_links": [{"key": "affiliated-issuer", "type": "definition", "offset": [51, 68]}, {"key": "executive-officer", "type": "clause", "offset": [84, 101]}, {"key": "general-partner", "type": "definition", "offset": [147, 162]}, {"key": "the-issuer", "type": "clause", "offset": [185, 195]}, {"key": "beneficial-owner", "type": "definition", "offset": [201, 217]}, {"key": "voting-equity-securities", "type": "clause", "offset": [278, 302]}, {"key": "basis-of", "type": "clause", "offset": [322, 330]}, {"key": "voting-power", "type": "clause", "offset": [331, 343]}, {"key": "any-capacity", "type": "definition", "offset": [387, 399]}, {"key": "at-the-time", "type": "clause", "offset": [400, 411]}, {"key": "officer-participating-in-the-offering", "type": "definition", "offset": [475, 512]}, {"key": "investment-manager", "type": "definition", "offset": [571, 589]}, {"key": "pooled-investment-fund", "type": "definition", "offset": [613, 635]}, {"key": "any-person", "type": "clause", "offset": [637, 647]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [679, 701]}, {"key": "solicitation-of-purchasers", "type": "clause", "offset": [720, 746]}, {"key": "in-connection-with", "type": "clause", "offset": [747, 765]}, {"key": "sale-of-securities", "type": "definition", "offset": [771, 789]}], "samples": [{"hash": "33sYPo57n1c", "uri": "https://www.riainabox.com/hubfs/Vermont-dfr-regulation-securities-s-2016-01-revised-121621.pdf", "label": "www.riainabox.com", "score": 10.9548254013, "published": false}, {"hash": "6EfYZxmjj7t", "uri": "https://dfr.vermont.gov/sites/finreg/files/doc_library/dfr-regulation-insurance-s-2016-01-proposed-rules-securities-regulations_0.pdf", "label": "dfr.vermont.gov", "score": 10.1704311371, "published": false}, {"hash": "gTBnY7kKrPO", "uri": "https://dfr.vermont.gov/sites/finreg/files/doc_library/dfr-regulation-insurance-s-2016-01-proposed-rules-securities-regulations-submitted-to-icar.pdf", "label": "dfr.vermont.gov", "score": 10.1704311371, "published": false}], "size": 7, "hash": "3f74818a2bfa60e7145c314dc5ea9ced", "id": 4}, {"snippet": "Status. The Purchaser hereby represents that neither it nor, to its knowledge, any of its Rule 506(d) Related Parties is a \u201cbad actor\u201d within the meaning of 506(d) promulgated under the Securities Act. For purposes of this Agreement, \u201cRule 506(d) Related Party\u201d shall mean a Person covered by the \u201cBad Actor disqualification\u201d provision of Rule 506(d) of the Securities Act.", "snippet_links": [{"key": "the-purchaser", "type": "definition", "offset": [8, 21]}, {"key": "represents-that", "type": "clause", "offset": [29, 44]}, {"key": "related-parties", "type": "definition", "offset": [102, 117]}, {"key": "meaning-of", "type": "definition", "offset": [146, 156]}, {"key": "the-securities-act", "type": "clause", "offset": [182, 200]}, {"key": "for-purposes-of-this-agreement", "type": "definition", "offset": [202, 232]}, {"key": "related-party", "type": "definition", "offset": [247, 260]}, {"key": "covered-by", "type": "definition", "offset": [282, 292]}, {"key": "bad-actor-disqualification", "type": "definition", "offset": [298, 324]}, {"key": "provision-of", "type": "clause", "offset": [326, 338]}], "samples": [{"hash": "kgrsKu8GiRC", "uri": "/contracts/kgrsKu8GiRC#bad-actor", "label": "Securities Purchase Agreement (Scientific Industries Inc)", "score": 36.3045845032, "published": true}, {"hash": "bKj875sGXLL", "uri": "/contracts/bKj875sGXLL#bad-actor", "label": "Securities Purchase Agreement (Scientific Industries Inc)", "score": 34.9520874023, "published": true}, {"hash": "lzNQzmEAfwK", "uri": "/contracts/lzNQzmEAfwK#bad-actor", "label": "Securities Purchase Agreement (Scientific Industries Inc)", "score": 33.1642723083, "published": true}], "size": 6, "hash": "673f1bad80adb355c43638c06593f9d0", "id": 5}, {"snippet": "Notice. Each party to this Agreement will promptly notify each other party to this Agreement in writing if it or, to its knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any Bad Actor Disqualification; provided, however, that, with respect to the Investors, such obligation under this Section 3.7 shall apply only if such Investor beneficially owns 20% or more of the Company\u2019s outstanding voting securities, calculated on the basis of voting power.", "snippet_links": [{"key": "party-to-this-agreement", "type": "clause", "offset": [13, 36]}, {"key": "promptly-notify", "type": "clause", "offset": [42, 57]}, {"key": "other-party", "type": "clause", "offset": [63, 74]}, {"key": "agreement-in-writing", "type": "clause", "offset": [83, 103]}, {"key": "any-person", "type": "clause", "offset": [132, 142]}, {"key": "the-securities-act", "type": "clause", "offset": [177, 195]}, {"key": "subject-to", "type": "clause", "offset": [204, 214]}, {"key": "bad-actor-disqualification", "type": "definition", "offset": [219, 245]}, {"key": "with-respect-to", "type": "clause", "offset": [272, 287]}, {"key": "the-investors", "type": "definition", "offset": [288, 301]}, {"key": "section-37", "type": "clause", "offset": [330, 341]}, {"key": "such-investor", "type": "clause", "offset": [362, 375]}, {"key": "beneficially-owns", "type": "definition", "offset": [376, 393]}, {"key": "of-the-company", "type": "clause", "offset": [406, 420]}, {"key": "outstanding-voting-securities", "type": "definition", "offset": [423, 452]}, {"key": "basis-of", "type": "clause", "offset": [472, 480]}, {"key": "voting-power", "type": "clause", "offset": [481, 493]}], "samples": [{"hash": "7XOa6Fd7P1I", "uri": "/contracts/7XOa6Fd7P1I#bad-actor", "label": "Investors\u2019 Rights Agreement (Juno Therapeutics, Inc.)", "score": 25.9363441467, "published": true}, {"hash": "4vfFG0kjoD6", "uri": "/contracts/4vfFG0kjoD6#bad-actor", "label": "Investors\u2019 Rights Agreement (Juno Therapeutics, Inc.)", "score": 25.8761119843, "published": true}, {"hash": "bE5j0PwuBQe", "uri": "/contracts/bE5j0PwuBQe#bad-actor", "label": "Investors\u2019 Rights Agreement (Juno Therapeutics, Inc.)", "score": 25.6954135895, "published": true}], "size": 6, "hash": "97156fed4269a8a51440c7fe626e8374", "id": 6}, {"snippet": "Covenant. In the event the Company proposes an offering of its securities in reliance on Rule 506 of the Securities Act, the Company intends to conduct an inquiry of all Investors that beneficially own 20% or more of the Company\u2019s then outstanding voting equity securities, calculated on the basis of voting power (each, a \u201c20% Holder\u201d), as to whether any 20% Holder or any Rule 506(d) Related Party of such 20% Holder is a \u201cbad actor\u201d within the meaning of Rule 506(d) promulgated under the Securities Act (each, a \u201cBad Actor\u201d). Each Stockholder hereby agrees that it shall provide information reasonably requested by the Company in order to conduct its inquiry within five (5) business days after the date of the Company\u2019s request therefor or as otherwise mutually agreed between such Stockholder and the Company. For purposes of this Agreement, \u201cRule 506(d) Related Party\u201d shall mean a person or entity covered by the \u201cBad Actor disqualification\u201d provision of Rule 506(d) of the Securities Act.", "snippet_links": [{"key": "in-the-event-the", "type": "clause", "offset": [10, 26]}, {"key": "reliance-on", "type": "clause", "offset": [77, 88]}, {"key": "rule-506", "type": "clause", "offset": [89, 97]}, {"key": "the-securities-act", "type": "clause", "offset": [101, 119]}, {"key": "all-investors", "type": "definition", "offset": [166, 179]}, {"key": "beneficially-own", "type": "clause", "offset": [185, 201]}, {"key": "of-the-company", "type": "clause", "offset": [214, 228]}, {"key": "voting-equity-securities", "type": "clause", "offset": [248, 272]}, {"key": "basis-of", "type": "clause", "offset": [292, 300]}, {"key": "voting-power", "type": "clause", "offset": [301, 313]}, {"key": "any-20", "type": "definition", "offset": [352, 358]}, {"key": "related-party", "type": "definition", "offset": [386, 399]}, {"key": "meaning-of", "type": "definition", "offset": [447, 457]}, {"key": "provide-information", "type": "clause", "offset": [575, 594]}, {"key": "in-order-to", "type": "clause", "offset": [631, 642]}, {"key": "days-after", "type": "definition", "offset": [688, 698]}, {"key": "date-of", "type": "clause", "offset": [703, 710]}, {"key": "mutually-agreed", "type": "clause", "offset": [758, 773]}, {"key": "and-the-company", "type": "clause", "offset": [799, 814]}, {"key": "for-purposes-of-this-agreement", "type": "definition", "offset": [816, 846]}, {"key": "person-or-entity", "type": "clause", "offset": [889, 905]}, {"key": "covered-by", "type": "definition", "offset": [906, 916]}, {"key": "bad-actor-disqualification", "type": "definition", "offset": [922, 948]}, {"key": "provision-of", "type": "clause", "offset": [950, 962]}], "samples": [{"hash": "95ostpWCWXn", "uri": "/contracts/95ostpWCWXn#bad-actor", "label": "Investors\u2019 Rights Agreement (Gossamer Bio, Inc.)", "score": 29.9691982269, "published": true}, {"hash": "1mzN9XiAsks", "uri": "/contracts/1mzN9XiAsks#bad-actor", "label": "Investors\u2019 Rights Agreement (Gossamer Bio, Inc.)", "score": 29.7748126984, "published": true}, {"hash": "8RJ9ZQwlnk2", "uri": "/contracts/8RJ9ZQwlnk2#bad-actor", "label": "Investors\u2019 Rights Agreement", "score": 24.1704311371, "published": true}], "size": 4, "hash": "0e5f4ddc3865b52f2f7c0415e0e47d27", "id": 7}, {"snippet": "Status. Purchaser is not a \u201cbad actor\u201d within the meaning of Rule 506(d) of Regulation D.", "snippet_links": [{"key": "meaning-of", "type": "definition", "offset": [50, 60]}], "samples": [{"hash": "e3JyTLGnB2R", "uri": "/contracts/e3JyTLGnB2R#bad-actor", "label": "Common Stock Purchase Agreement (Braeburn Pharmaceuticals, Inc.)", "score": 28.0718688965, "published": true}, {"hash": "iV4ImQBIIpc", "uri": "/contracts/iV4ImQBIIpc#bad-actor", "label": "Securities Purchase Agreement (Oncobiologics, Inc.)", "score": 27.3791923523, "published": true}, {"hash": "ivRgsZYcOEP", "uri": "/contracts/ivRgsZYcOEP#bad-actor", "label": "Common Stock Purchase Agreement (Intellia Therapeutics, Inc.)", "score": 27.3189601898, "published": true}], "size": 4, "hash": "680b899046bd281269ce28f51f4a3eaf", "id": 8}, {"snippet": "Status. Subscriber hereby warrants that neither it nor any of its Rule 506(d) Related Parties is a \u201cbad actor\u201d within the meaning of Rule 506(d) promulgated under the Securities Act.", "snippet_links": [{"key": "related-parties", "type": "definition", "offset": [78, 93]}, {"key": "meaning-of", "type": "definition", "offset": [122, 132]}, {"key": "the-securities-act", "type": "clause", "offset": [163, 181]}], "samples": [{"hash": "hUNrjRqwkbk", "uri": "/contracts/hUNrjRqwkbk#bad-actor", "label": "Subscription Agreement (LumiraDx LTD)", "score": 33.544834137, "published": true}, {"hash": "dgOCw95tQcR", "uri": "/contracts/dgOCw95tQcR#bad-actor", "label": "Subscription Agreement (Immunocore Holdings PLC)", "score": 32.0910339355, "published": true}, {"hash": "gIXxKipUV8z", "uri": "/contracts/gIXxKipUV8z#bad-actor", "label": "Subscription Agreement (Immunocore LTD)", "score": 32.0855560303, "published": true}], "size": 4, "hash": "88594e550d86380f78ac8b59ad5f142f", "id": 9}, {"snippet": "Disqualification. The Buyer represents and warrants on behalf of itself and its Affiliates that neither: (x) such Person; nor (y) any entity that controls such Person or is under the control of, or under common control with, such Person; nor (z) any director of the Company that has been designated by such Person, if applicable; is subject to any Disqualification Event (as defined in Section 3(k)(6) below), except for Disqualification Events covered by Rule 506(d)(2)(ii) or (iii) under the 1933 Act and disclosed in writing in reasonable detail to the Company. Buyer represents that it has exercised reasonable care to determine the accuracy of the representation made by it this Section 2(m) and agrees to notify the Company if it becomes aware of any fact that makes the representation given by it hereunder inaccurate.", "snippet_links": [{"key": "buyer-represents", "type": "clause", "offset": [22, 38]}, {"key": "on-behalf-of", "type": "definition", "offset": [52, 64]}, {"key": "control-of", "type": "definition", "offset": [183, 193]}, {"key": "under-common-control", "type": "definition", "offset": [198, 218]}, {"key": "director-of-the-company", "type": "definition", "offset": [250, 273]}, {"key": "if-applicable", "type": "definition", "offset": [315, 328]}, {"key": "subject-to", "type": "clause", "offset": [333, 343]}, {"key": "defined-in-section", "type": "clause", "offset": [375, 393]}, {"key": "disqualification-events", "type": "definition", "offset": [421, 444]}, {"key": "covered-by", "type": "definition", "offset": [445, 455]}, {"key": "the-1933-act", "type": "clause", "offset": [490, 502]}, {"key": "disclosed-in-writing", "type": "clause", "offset": [507, 527]}, {"key": "to-the-company", "type": "definition", "offset": [549, 563]}, {"key": "represents-that", "type": "clause", "offset": [571, 586]}, {"key": "reasonable-care", "type": "clause", "offset": [604, 619]}, {"key": "determine-the", "type": "clause", "offset": [623, 636]}, {"key": "accuracy-of-the", "type": "clause", "offset": [637, 652]}, {"key": "agrees-to", "type": "clause", "offset": [701, 710]}, {"key": "notify-the", "type": "clause", "offset": [711, 721]}], "samples": [{"hash": "jn3M47TTwpj", "uri": "/contracts/jn3M47TTwpj#bad-actor", "label": "Purchase Agreement (Xg Sciences Inc)", "score": 27.069814682, "published": true}, {"hash": "i8s6ABbrsOP", "uri": "/contracts/i8s6ABbrsOP#bad-actor", "label": "Purchase Agreement (Xg Sciences Inc)", "score": 27.069814682, "published": true}, {"hash": "dRsU2KKWlul", "uri": "/contracts/dRsU2KKWlul#bad-actor", "label": "Purchase Agreement (Xg Sciences Inc)", "score": 27.069814682, "published": true}], "size": 3, "hash": "98d1751ec66ba181694574ee83bac220", "id": 10}], "next_curs": "ClYSUGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjILEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiISYmFkLWFjdG9yIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "Notice. Each party to this Agreement will promptly notify each other party to this Agreement in writing if it or, to its knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any Bad Actor Disqualification.", "size": 127, "title": "Bad Actor", "id": "bad-actor", "examples": ["The Purchaser will promptly notify the Company in writing if the Purchaser or, to the Purchaser\u2019s knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any <strong>Bad Actor</strong> Disqualification.", "The Subscriber hereby represents and warrants that it is not a <strong>Bad Actor</strong> (as defined below) and that no Bad Act (as defined below) exists with respect to the Subscriber or any person that indirectly controls the voting of the Subscriber\u2019s Securities.", "The Subscriber agrees to provide the Fund any information that the Fund may reasonably request in order to determine whether the Subscriber or any person that indirectly controls the voting of the Subscriber\u2019s Securities is a <strong>Bad Actor</strong>, including, without limitation, filings with, and records of, courts and regulators.", "The Company agrees to engage a securities attorney or securities compliance company for a review of any and all Test the Waters material appearing on the Platform prior to posting said material on the Platform and the Company shall provide all necessary information and fees to complete the <strong>Bad Actor</strong> Check for compliance with Reg A Rule 262 prior to appearing on the Platform.", "The Purchaser is not subject to any of the &quot;<strong>Bad Actor</strong>&quot; disqualifications described in Rule 506(d)(l)(i) to (viii) under the Securities Act (a &quot;Disqualification Event&quot;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).", "In order to confirm that the Company remains eligible to rely on Rule 506 and to comply with the related disclosure requirements, each director, executive officer, general partner or managing member of the company, or beneficial owner of 20% or more of the company\u2019s outstanding voting equity securities, is required to complete and execute this <strong>Bad Actor</strong> Disqualification Questionnaire (this \u201cQuestionnaire\u201d).", "The Company agrees to engage Crowdcheck for a review of any and all Test the Waters material appearing on the Platform prior to posting said material on the Platform and the Company shall provide all necessary information and fees for Crowdcheck to complete the <strong>Bad Actor</strong> Check.", "With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Purchasers at the time of sale is subject to any of the &quot;<strong>Bad Actor</strong>&quot; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act, except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3).", "A form of Rule 506 <strong>Bad Actor</strong> Disqualification Questionnaire is attached hereto as Exhibit F.", "A form of Rule 506 <strong>Bad Actor</strong> Disqualification Questionnaire is attached hereto as Exhibit E."], "related": [["actor", "Actor", "Actor"], ["capital-disqualification-event", "Capital Disqualification Event", "Capital Disqualification Event"], ["rule-506d-related-party", "Rule 506(d) Related Party", "Rule 506(d) Related Party"], ["disqualification-event", "Disqualification Event", "Disqualification Event"], ["rule-17f-7", "Rule 17f-7", "Rule 17f-7"]], "related_snippets": [], "updated": "2026-04-19T04:24:51+00:00"}, "json": true, "cursor": ""}}